Status:
UNKNOWN
COVID 19 ANTOBODIES IN PREGNANT WOMEN AND THEIR CONNECTION TO BETA CELL FUNCTION IN THE FETUS
Lead Sponsor:
Maaynei Hayesha Medical Center
Conditions:
Generation of Anti COVID-19 Antibodies in a Fetus, Whose Mother Was Exposed to COVID or Was Vaccinated During Pregnancy
Eligibility:
FEMALE
18-48 years
Brief Summary
The aim of this study is to check for the presence of COVID 19 antibodies \[Covid-19, GAD-65, IA-2, ICA\] in the blood of laboring women who have been exposed to either the virus itself or to the vacc...
Detailed Description
T1D is caused by an autoimmune reaction to proteins that cause the destruction of the pancreatic beta cells. The incidence of childhood Type 1 diabetes (T1D) is continuously increasing, caused by envi...
Eligibility Criteria
Inclusion
- exposure to the COVID 19 virus or vaccine during pregnancy
Exclusion
- \- Age under 18 or over 48 IUFD
Key Trial Info
Start Date :
April 26 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04860908
Start Date
April 26 2021
End Date
July 1 2022
Last Update
April 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maayanei Hayeshua Medical Center
Bnei Brak, Central District, Israel